Tenet Healthcare Stock
Tenet Healthcare Stock
A loss of -2.700% shows a downward development for Tenet Healthcare.
The stock is an absolute favorite of our community with 45 Buy predictions and no Sell predictions.
However, we have a potential of -0.92% for Tenet Healthcare as the target price of 216 € is below the current price of 218.0 €.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | -2.700% | 1.869% | 22.472% | 59.124% | 25.287% | 220.588% | 259.262% |
| Chemed Corp. | -0.430% | 2.691% | 8.019% | 27.222% | 25.824% | - | - |
| Davita Inc. | 3.120% | -2.262% | -1.979% | 69.674% | 110.597% | 118.858% | 95.571% |
| Molina Healthcare | -0.290% | -3.560% | -16.063% | 26.296% | 15.959% | -39.188% | -26.710% |
Comments
Tenet Healthcare (THC) had its "overweight" rating reaffirmed by Wells Fargo & Company.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) had its price target raised by Truist Financial Corporation from $270.00 to $290.00. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) was given a new $308.00 price target by UBS Group AG. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat